quarterly, page-7

If the august announcement is to be believed, will be sufficient funds to keep us going for 18 months after all revenue reduction strategies have been implemented.

Relevant part of the August 2011 announcement

"The Company’s cost reduction plan will include terminating all material contracts and making all employees redundant by the end of November 2011. Dr Jenny Harry CEO and other key executives will be available until February 2012 to assist with the pursuit and implementation of the licensing or sale of the Company’s core intellectual property assets and other alternative strategic options.
The Company estimates that the costs of implementing this revised strategy, including redundancy payments and early termination payments under contracts, will be approximately $1.6million. After implementing these changes, the Company estimates that it will have sufficient cash reserves to fund its reduced operations for a further 18 months."

Since that point they have 2 licensing agreements which will generate additional funds, plus whatever money comes our way from the Bayer settlement.

All assuming of course that these board members have some integrity. I'm along for the ride for a little longer, but have no idea how this story is going to end.